A senior psychologist at Britain's University of Birmingham says he has found good evidence that fetuses cannot feel pain.
Stuart Derbyshire says his study indicates proposals to tell women seeking abortions that their unborn child will feel pain, or to provide pain relief during abortions, are scientifically unsound and may put women at unnecessary risk.
Derbyshire examined the neurological and psychological evidence to support a concept of fetal pain. He says he concluded that although still immature, the neural circuitry necessary for processing pain can be considered complete by 26 weeks' gestation.
He argues pain experience requires not only development of the brain, but also development of the mind to accommodate the subjectivity of pain. And he says development of the mind only occurs outside the womb.
He said the biological development to support pain experience is ongoing, but the environment after birth -- necessary to the development of pain experience -- is yet to occur. So, he says, as such, fetuses cannot experience pain.
Derbyshire says, however, the absence of pain in the fetus does not resolve the question of the morality of abortion.
Copyright 2006 by United Press International
Related stories:
Study reveals that signs of heart disease are attributed to stress more frequently in women than men
Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), found that coronary heart disease (CHD) symptoms presented in the context of a stressful life event were identified as psychogenic in origin when presented by women and organic in origin when presented by men. The study could help explain why there is often a delay in the assessment of women with heart disease.
Out of Iraq emerges hope for those with the severest of head injuries
There may be more hope than has been recognized for some people with severe brain injuries, according to a U.S. neurosurgeon who earlier this year spent four months in Iraq treating soldiers and civilians. Jason Huang, M.D., this week presented his results from his experience in Iraq at the annual meeting of the Congress of Neurological Surgeons in Orlando, Fla.
A molecule keeps anxiety down
(PhysOrg.com) -- The link between emotions and experiences determines many aspects of our daily life. It allows us to recognize pretty objects or harmful situations. These links are created when nerve cells construct new connections to one another or reinforce existing connections. Scientists at the Max Planck Institutes for Neurobiology and Psychiatry and at the Großhadern Clinic (Ludwig Maximilian University) have now discovered a molecule with a crucial influence on the strength of these connections (
PNAS, August 4, 2008).
Researching the power of the placebo effect in arthritis patients
(PhysOrg.com) -- People with arthritis are to take part in new research carried out at The University of Manchester to find out more about how the placebo effect works.
Researchers find differences in swallowing mechanism of Rett syndrome patients
Researchers at Wake Forest University Baptist Medical Center have found that the reflux and swallowing problems that are common symptoms in patients with Rett syndrome and other neurological impairments, may be caused by a different mechanism than they are in healthy individuals. The finding leaves researchers to wonder if these patients truly benefit from anti-reflux surgery commonly performed in these children.
Emotional robots in the spotlight
(PhysOrg.com) -- A robot with empathy sounds like the stuff of sci-fi movies, but with the aid of neural networks European researchers are developing robots in tune with our emotions. The tantalising work of the Feelix Growing project is grabbing the world’s attention.
Newly approved ocular safety methods reduce animal testing
Federal regulatory agencies have accepted recommendations of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) for two methods that can reduce live animal use for ocular safety testing, the committee announced today. ICCVAM is a permanent interagency committee composed of representatives from 15 federal regulatory and research agencies, including the National Institutes of Health (NIH) that use, generate or disseminate toxicology testing information.
The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation
Simpler approach to atrial fibrillation treatment in heart failure patients eliminates need for repeated cardioversions and reduces hospitalization rates
The results of a major international clinical trial coordinated by the Montreal Heart Institute were reported in the New England Journal of Medicine. The Atrial Fibrillation and Congestive Heart Failure Trial (AF-CHF) was a prospective, multicentre project involving patients with heart failure and atrial fibrillation.